Article Details
Retrieved on: 2022-10-26 09:40:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca said yesterday that its asthma drug Fasenra failed to meet one of the two main goals of a late-stage study assessing the treatment's ...
Article found on: www.expresspharma.in
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here